Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-850-6 | CAS number: 1245638-61-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From September 30, 1980 to March 17, 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to the equivalent of standard guidelines.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- Method: 40 CFR Part 163.81-1 (Environmental Protection Agency Pesticide Programs. Proposed Guidelines for Registering Pesticides in the U.S.; Hazard Evaluation: Humans and Domestic Animals. Acute Oral Toxicity Study)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 2-Propenoic acid, reaction products with pentaerythritol
- EC Number:
- 629-850-6
- Cas Number:
- 1245638-61-2
- Molecular formula:
- Not available for this UVCB.
- IUPAC Name:
- 2-Propenoic acid, reaction products with pentaerythritol
- Details on test material:
- Name of test material (as cited in study report): SN-2196, C-171, JAB 318-80
Physical state: Viscous, clear liquid
Density: 1.1788 g/mL
Storage condition of test material: Stored at room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Wilmington, Massachusetts
- Age at study initiation: Young adults
- Weight at study initiation: Males: 247-335 g and females: 213-254 g
- Fasting period before study: Overnight
- Housing: Six animals/cage in suspended, stainless steel with wire-mesh bottoms
- Diet (e.g. ad libitum): Purina Laboratory Rodent Diet, ad libitum
- Water (e.g. ad libitum): Municipal water, ad libitum
- Acclimation period: 14-28 d
ENVIRONMENTAL CONDITIONS
- Temperature (°F): 64-78 °F
- Photoperiod (h dark / h light): 12 h dark / 12 h light
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 1 % methylcellulose
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 0.04 - 4.2 mL/kg - Doses:
- Range-finding test: 50, 100, 500, 1,000, 2,000 or 5,000 mg/kg bw
LD50 determination: 250, 350, 500, 700, 1,000, 1,400 or 2,000 mg/kg bw - No. of animals per sex per dose:
- Range-finding screen: 5/sex (at 5,000 mg/kg bw); one/sex/dose (at other doses)
LD50 determination: 5/sex/dose - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 d
- Frequency of observations: Pharmacological and toxicological signs were observed approximately 1, 2, and 4 h after dosing and daily thereafter for 14 d; weighing done at pre-fast, post-fast (just prior to dosing), day 7 and 14 or at terminal sacrifice
- Necropsy of survivors performed: Yes; surviving animals were killed by carbon dioxide inhalation - Statistics:
- Mortality data were analyzed by probit analysis method.
Results and discussion
- Preliminary study:
- Not applicable
Effect levelsopen allclose all
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 620 mg/kg bw
- 95% CL:
- > 480 - < 760
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 420 mg/kg bw
- 95% CL:
- > 340 - < 500
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 540 mg/kg bw
- 95% CL:
- > 440 - < 640
- Mortality:
- Range-finding agent:
- 0/2, 0/2, 0/1, 1/2, 2/2 and 10/10 animals died at 50, 100, 500, 1,000, 2,000 and 5,000 mg/kg bw, respectively
LD50 determination test:
- 0/9, 2/10, 4/10, 9/10, 8/9, 10/10 and 8/8 animals died at 250, 350, 500, 700, 1,000, 1,400 and 2,000 mg/kg, respectively - Clinical signs:
- other: - Decreased activity, dyspnea, soft stool, fecal staining, oral discharge, hypopnea and rales were observed at all dose levels - No unusual clinical signs were observed in the surviving animals
- Gross pathology:
- Examinations of animals which died revealed a variety of changes, primarily in the lungs and gastrointestinal tract; most of these were considered to represent post-mortem changes.
- Other findings:
- None
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the study, the acute oral LD50 of the substance in male and female rats was calculated to be 620 (480-760) and 420 (340-500) mg/kg bw. The combined LD50 for male/female rats was calculated to be 540 (440-640) mg/kg bw.
- Executive summary:
A study was conducted to assess the single dose toxicity of C-171 in Sprague-Dawley rats using a method equivalent or similar to OECD Guideline 401.
Groups of 10 Sprague-Dawley rats (5/sex/dose) received a single oral (gavage) dose of 250, 350, 500, 700, 1,000, 1,400 or 2,000 mg/kg bw. Parameters evaluated included survival, clinical observations, body weight and necropsy findings in all animals after a 14 day observation period.
Mortality was 0/9 at 250 mg/kg bw, 2/10 at 350 mg/kg bw, 4/10 at 500 mg/kg bw, 9/10 at 700 mg/kg bw, 8/9 at 1,000 mg/kg bw, 10/10 at 1,400 mg/kg bw and 8/8 at 2,000 mg/kg bw. All surviving animals showed gains in body weight between Days 7-14. Necropsy of animals which died prior to termination revealed a variety of changes, primarily in the lungs and gastrointestinal tract, most of which were considered to represent post-mortem changes.
Clinical signs noted at all dose levels were decreased activity, dyspnea, soft stool, fecal staining, oral discharge, hypopnea and rales. No unusual clinical signs were observed in the surviving animals.
In conclusion, under the conditions of the study, the acute oral LD50 of the substance in male/female rats was calculated to be 620 (480 -760) and 420 (340 -500) mg/kg bw. The combined LD50 for male/female rats was calculated to be 540 (440 -640) mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
